Role of pulmonary microvascular endothelial cell apoptosis in murine sepsis-induced lung injury in vivo

Respiratory Research

Volumn 16, Issue 1, 2015, Pages

  Gill, Sean E ^a,b   Rohan, Marta ^a   Mehta, Sanjay ^a,b,c  

^a LAWSON HEALTH RESEARCH INSTITUTE   (Canada)

^b WESTERN UNIVERSITY   (Canada)

^c LONDON HEALTH SCIENCES CENTRE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; APOCYNIN; CASPASE; EVANS BLUE; INDUCIBLE NITRIC OXIDE SYNTHASE; PHOSPHATIDYLSERINE; PROPIDIUM IODIDE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; CASPASE INHIBITOR; CYBB PROTEIN, MOUSE; LIPOCORTIN 5; MEMBRANE PROTEIN; NEUTROPHIL CYTOSOLIC FACTOR 1; NOS2 PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CAPILLARY ENDOTHELIAL CELL; CECAL LIGATION AND PUNCTURE-INDUCED SEPSIS; CONTROLLED STUDY; DNA FRAGMENTATION; ENZYME ACTIVATION; FLUORESCENCE INTRAVITAL VIDEOMICROSCOPY; FLUORESCENCE MICROSCOPY; HISTOLOGY; HUMAN; IN VITRO STUDY; IN VIVO STUDY; LUNG INJURY; MALE; MOUSE; NONHUMAN; PERMEABILITY BARRIER; SIGNAL TRANSDUCTION; TUNEL ASSAY; VIDEO MICROSCOPY; ACUTE LUNG INJURY; ANIMAL; C57BL MOUSE; CAPILLARY PERMEABILITY; COMPLICATION; DISEASE MODEL; DRUG EFFECTS; ENDOTHELIUM CELL; GENETICS; KNOCKOUT MOUSE; LUNG; METABOLISM; MICROVASCULATURE; PATHOLOGY; SEPSIS; TIME FACTOR; VASCULARIZATION;

ACUTE LUNG INJURY; ANIMALS; ANNEXIN A5; APOPTOSIS; CAPILLARY PERMEABILITY; CASPASE INHIBITORS; CASPASES; DISEASE MODELS, ANIMAL; DNA FRAGMENTATION; ENDOTHELIAL CELLS; ENZYME ACTIVATION; LUNG; MALE; MEMBRANE GLYCOPROTEINS; MICE, INBRED C57BL; MICE, KNOCKOUT; MICROVESSELS; NADPH OXIDASE; NITRIC OXIDE SYNTHASE TYPE II; PHOSPHATIDYLSERINES; SEPSIS; SIGNAL TRANSDUCTION; TIME FACTORS;

EID: 84941645021     PISSN: 14659921     EISSN: 1465993X     Source Type: Journal    
DOI: 10.1186/s12931-015-0266-7     Document Type: Article

References (92)

1. Ferrer R, Artigas A, Suarez D, Palencia E, Levy MM, Arenzana A, et al. Effectiveness of treatments for severe sepsis: a prospective, multicenter, observational study. Am J Respir Crit Care Med. 2009;180:861-6.
2. Husak L, Marcuzzi A, Herring J, Wen E, Yin L, Capan DD, et al. National analysis of sepsis hospitalizations and factors contributing to sepsis in-hospital mortality in Canada. Healthc Q. 2010;13:Spec No:35-41.
3. Angus DC, van der Poll T. Severe sepsis and septic shock. N Engl J Med. 2013;369:2063-3.
4. Angus DC, Linde-Zwirble WT, Lidicker J, Clermont G, Carcillo J, Pinsky MR. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med. 2001;29:1303-10.
5. Hotchkiss RS, Karl IE. The pathophysiology and treatment of sepsis. N Engl J Med. 2003;348:138-50.
6. Sandrock CE, Albertson TE. Controversies in the treatment of sepsis. Semin Respir Crit Care Med. 2010;31:66-78.
7. King EG, Bauzá GJ, Mella JR, Remick DG. Pathophysiologic mechanisms in septic shock. Lab Invest. 2014;94:4-12.
8. Stearns-Kurosawa DJ, Osuchowski MF, Valentine C, Kurosawa S, Remick DG. The pathogenesis of sepsis. Annu Rev Pathol. 2011;6:19-48.
9. Glauser MP. Pathophysiologic basis of sepsis: considerations for future strategies of intervention. Crit Care Med. 2000;28:S4-8.
10. Wheeler AP, Bernard GR. Acute lung injury and the acute respiratory distress syndrome: a clinical review. Lancet. 2007;369:1553-64.
11. Dellinger RP, Levy MM, Rhodes A, Annane D, Gerlach H, Opal SM, et al. Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012. Crit Care Med. 2013;41:580-637.
12. Deutschman CS, Tracey KJ. Sepsis: current dogma and new perspectives. Immunity. 2014;40:463-75.
13. De Backer D, Creteur J, Preiser J-C, Dubois M-J, Vincent J-L. Microvascular blood flow is altered in patients with sepsis. Am J Respir Crit Care Med. 2002;166:98-104.
14. Trzeciak S, Dellinger RP, Parrillo JE, Guglielmi M, Bajaj J, Abate NL, et al. Early microcirculatory perfusion derangements in patients with severe sepsis and septic shock: relationship to hemodynamics, oxygen transport, and survival. Ann Emerg Med. 2007;49:88-98. 98.e1-2.
15. Edul VSK, Enrico C, Laviolle B, Vazquez AR, Ince C, Dubin A. Quantitative assessment of the microcirculation in healthy volunteers and in patients with septic shock. Crit Care Med. 2012;40:1443-8.
16. Sakr Y, Dubois M-J, De Backer D, Creteur J, Vincent J-L. Persistent microcirculatory alterations are associated with organ failure and death in patients with septic shock. Crit Care Med. 2004;32:1825-31.
17. Razavi HM, Wang LF, Weicker S, Rohan M, Law C, McCormack DG, et al. Pulmonary neutrophil infiltration in murine sepsis: role of inducible nitric oxide synthase. Am J Respir Crit Care Med. 2004;170:227-33.
18. Wang L, Taneja R, Razavi HM, Law C, Gillis C, Mehta S. Specific role of neutrophil inducible nitric oxide synthase in murine sepsis-induced lung injury in vivo. Shock. 2012;37:539-47.
19. Wang LF, Patel M, Razavi HM, Weicker S, Joseph MG, McCormack DG, et al. Role of Inducible Nitric Oxide Synthase in Pulmonary Microvascular Protein Leak in Murine Sepsis. Am J Respir Crit Care Med. 2002;165:1634-9.
20. Vallet B. Endothelial cell dysfunction and abnormal tissue perfusion. Crit Care Med. 2002;30:S229-34.
21. Schmidt EP, Lee WL, Zemans RL, Yamashita C, Downey GP. On, around, and through: neutrophil-endothelial interactions in innate immunity. Physiology (Bethesda). 2011;26:334-47.
22. De Backer D, Orbegozo Cortes D, Donadello K, Vincent J-L. Pathophysiology of microcirculatory dysfunction and the pathogenesis of septic shock. Virulence. 2014;5:73-9.
23. Ware LB, Matthay MA. The acute respiratory distress syndrome. N Engl J Med. 2000;342:1334-49.
24. De Backer D, Donadello K, Taccone FS, Ospina-Tascon G, Salgado D, Vincent J-L. Microcirculatory alterations: potential mechanisms and implications for therapy. Ann Intensive Care. 2011;1:27.
25. Cines DB, Pollak ES, Buck CA, Loscalzo J, Zimmerman GA, McEver RP, et al. Endothelial cells in physiology and in the pathophysiology of vascular disorders. Blood. 1998;91:3527-61.
26. Reinhart K, Bayer O, Brunkhorst F, Meisner M. Markers of endothelial damage in organ dysfunction and sepsis. Crit Care Med. 2002;30:S302-12.
27. Xing K, Murthy S, Liles WC, Singh JM. Clinical utility of biomarkers of endothelial activation in sepsis--a systematic review. Crit Care. 2012;16:R7.
28. Shapiro NI, Aird WC. Sepsis and the broken endothelium. Crit Care. 2011;15:135.
29. Skibsted S, Jones AE, Puskarich MA, Arnold R, Sherwin R, Trzeciak S, et al. Biomarkers of endothelial cell activation in early sepsis. Shock. 2013;39:427-32.
30. Sukriti S, Tauseef M, Yazbeck P, Mehta D. Mechanisms regulating endothelial permeability. Pulm Circ. 2014;4:535-51.
31. Mehta D, Ravindran K, Kuebler WM. Novel regulators of endothelial barrier function. Am J Physiol Lung Cell Mol Physiol. 2014;307:L924-35.
32. Opal SM, van der Poll T. Endothelial barrier dysfunction in septic shock. J Intern Med. 2015;277:277-93.
33. Kása A, Csortos C, Verin AD. Cytoskeletal mechanisms regulating vascular endothelial barrier function in response to acute lung injury. Tissue Barriers. 2015;3:e974448.
34. Mehta S. The effects of nitric oxide in acute lung injury. Vascul Pharmacol. 2005;43:390-403.
35. Razavi HM, Wang L, Weicker S, Quinlan GJ, Mumby S, McCormack DG, et al. Pulmonary oxidant stress in murine sepsis is due to inflammatory cell nitric oxide. Crit Care Med. 2005;33:1333-9.
36. Farley KS, Wang LF, Razavi HM, Law C, Rohan M, McCormack DG, et al. Effects of macrophage inducible nitric oxide synthase in murine septic lung injury. Am J Physiol Lung Cell Mol Physiol. 2006;290:L1164-72.
37. Gill SE, Taneja R, Rohan M, Wang L, Mehta S. Pulmonary Microvascular Albumin Leak Is Associated with Endothelial Cell Death in Murine Sepsis-Induced Lung Injury In Vivo. PLoS ONE. 2014;9:e88501.
38. Haimovitz-Friedman A, Cordon-Cardo C, Bayoumy S, Garzotto M, McLoughlin M, Gallily R, et al. Lipopolysaccharide induces disseminated endothelial apoptosis requiring ceramide generation. J Exp Med. 1997;186:1831-41.
39. Hotchkiss RS, Tinsley KW, Swanson PE, Karl IE. Endothelial cell apoptosis in sepsis. Crit Care Med. 2002;30:S225-8.
40. Hu H, Li X, Li Y, Wang L, Mehta S, Feng Q, et al. Calpain-1 induces apoptosis in pulmonary microvascular endothelial cells under septic conditions. Microvasc Res. 2009;78:33-9.
41. Fujita M, Kuwano K, Kunitake R, Hagimoto N, Miyazaki H, Kaneko Y, et al. Endothelial cell apoptosis in lipopolysaccharide-induced lung injury in mice. Int Arch Allergy Immunol. 1998;117:202-8.
42. Matsuda N, Teramae H, Yamamoto S, Takano K-I, Takano Y, Hattori Y. Increased death receptor pathway of apoptotic signaling in septic mouse aorta: effect of systemic delivery of FADD siRNA. Am J Physiol Heart Circ Physiol. 2010;298:H92-H101.
43. Matsuda N, Takano Y, Kageyama S-I, Hatakeyama N, Shakunaga K, Kitajima I, et al. Silencing of caspase-8 and caspase-3 by RNA interference prevents vascular endothelial cell injury in mice with endotoxic shock. Cardiovasc Res. 2007;76:132-40.
44. Subbanna S, Shivakumar M, Umapathy NS, Saito M, Mohan PS, Kumar A, et al. G9a-mediated histone methylation regulates ethanol-induced neurodegeneration in the neonatal mouse brain. Neurobiol Dis. 2013;54:475-85.
45. Starr A, Graepel R, Keeble J, Schmidhuber S, Clark N, Grant A, et al. A reactive oxygen species-mediated component in neurogenic vasodilatation. Cardiovasc Res. 2008;78:139-47.
46. Razavi HM, Werhun R, Scott JA, Weicker S, Wang LF, McCormack DG, et al. Effects of inhaled nitric oxide in a mouse model of sepsis-induced acute lung injury. Crit Care Med. 2002;30:868-73.
47. Wang L, Mehta S, Gillis C, Law C, Taneja R. Modulation of neutrophil apoptosis by murine pulmonary microvascular endothelial cell inducible nitric oxide synthase. Biochem Biophys Res Commun. 2010;401:207-12.
48. Semeraro N, Ammollo CT, Semeraro F, Colucci M. Sepsis, thrombosis and organ dysfunction. Thromb Res. 2012;129:290-5.
49. Tyml K. Critical role for oxidative stress, platelets, and coagulation in capillary blood flow impairment in sepsis. Microcirculation. 2011;18:152-62.
50. Darwish I, Liles WC. Emerging therapeutic strategies to prevent infection-related microvascular endothelial activation and dysfunction. Virulence. 2013;4:572-82.
51. Granger DN, Kubes P. The microcirculation and inflammation: modulation of leukocyte-endothelial cell adhesion. J Leukoc Biol. 1994;55:662-75.
52. Lam C, Tyml K, Martin C, Sibbald W. Microvascular perfusion is impaired in a rat model of normotensive sepsis. J Clin Invest. 1994;94:2077-83.
53. Boerma EC, van der Voort PHJ, Spronk PE, Ince C. Relationship between sublingual and intestinal microcirculatory perfusion in patients with abdominal sepsis. Crit Care Med. 2007;35:1055-60.
54. Manicone AM. Role of the pulmonary epithelium and inflammatory signals in acute lung injury. Expert Rev Clin Immunol. 2009;5:63-75.
55. Perl M, Lomas-Neira J, Venet F, Chung C-S, Ayala A. Pathogenesis of indirect (secondary) acute lung injury. Expert Rev Respir Med. 2011;5:115-26.
56. Ware LB, Matthay MA. Alveolar fluid clearance is impaired in the majority of patients with acute lung injury and the acute respiratory distress syndrome. Am J Respir Crit Care Med. 2001;163:1376-83.
57. Wang L, Bastarache JA, Wickersham N, Fang X, Matthay MA, Ware LB. Novel role of the human alveolar epithelium in regulating intra-alveolar coagulation. Am J Respir Cell Mol Biol. 2007;36:497-503.
58. Bastarache JA, Fremont RD, Kropski JA, Bossert FR, Ware LB. Procoagulant alveolar microparticles in the lungs of patients with acute respiratory distress syndrome. Am J Physiol Lung Cell Mol Physiol. 2009;297:L1035-41.
59. Wang L, Taneja R, Wang W, Yao L-J, Veldhuizen RAW, Gill SE, et al. Human alveolar epithelial cells attenuate pulmonary microvascular endothelial cell permeability under septic conditions. PLoS ONE. 2013;8:e55311.
60. Shelton JL, Wang L, Cepinskas G, Sandig M, Inculet R, McCormack DG, et al. Albumin leak across human pulmonary microvascular vs. umbilical vein endothelial cells under septic conditions. Microvasc Res. 2006;71:40-7.
61. Shelton JL, Wang L, Cepinskas G, Sandig M, Scott JA, North ML, et al. Inducible NO synthase (iNOS) in human neutrophils but not pulmonary microvascular endothelial cells (PMVEC) mediates septic protein leak in vitro. Microvasc Res. 2007;74:23-31.
62. Farley KS, Wang LF, Law C, Mehta S. Alveolar macrophage inducible nitric oxide synthase-dependent pulmonary microvascular endothelial cell septic barrier dysfunction. Microvasc Res. 2008;76:208-16.
63. Shelton JL, Wang L, Cepinskas G, Inculet R, Mehta S. Human neutrophil-pulmonary microvascular endothelial cell interactions in vitro: differential effects of nitric oxide vs. peroxynitrite. Microvasc Res. 2008;76:80-8.
64. Farley KS, Wang L, Mehta S. Septic pulmonary microvascular endothelial cell injury: role of alveolar macrophage NADPH oxidase. Am J Physiol Lung Cell Mol Physiol. 2009;296:L480-8.
65. Galluzzi L, Vitale I, Abrams JM, Alnemri ES, Baehrecke EH, Blagosklonny MV, et al. Molecular definitions of cell death subroutines: recommendations of the Nomenclature Committee on Cell Death 2012. Cell Death Differ. 2011;19:107-20.
66. Galluzzi L, Bravo-San Pedro JM, Vitale I, Aaronson SA, Abrams JM, Adam D, et al. Essential versus accessory aspects of cell death: recommendations of the NCCD 2015. Cell Death Differ. 2015;22:58-73.
67. Fink SL, Cookson BT. Apoptosis, Pyroptosis, and Necrosis: Mechanistic Description of Dead and Dying Eukaryotic Cells. Infect Immun. 2005;73:1907-16.
68. Qing DY, Conegliano D, Shashaty MGS, Seo J, Reilly JP, Worthen GS, et al. Red Blood Cells Induce Necroptosis of Lung Endothelial Cells and Increase Susceptibility to Lung Inflammation. Am J Respir Crit Care Med. 2014;190:1243-54.
69. Maurer K, Reyes-Robles T, Alonzo III F, Durbin J, Torres VJ, Cadwell K. Autophagy Mediates Tolerance to Staphylococcus aureus Alpha-Toxin. Cell Host Microbe. 2015;17:429-40.
70. Kovarova M, Hesker PR, Jania L, Nguyen M, Snouwaert JN, Xiang Z, et al. NLRP1-Dependent Pyroptosis Leads to Acute Lung Injury and Morbidity in Mice. J Immunol. 2012;189:2006-16.
71. Hemmer CJ, Vogt A, Unverricht M, Krause R, Lademann M, Reisinger EC. Malaria and bacterial sepsis: similar mechanisms of endothelial apoptosis and its prevention in vitro. Crit Care Med. 2008;36:2562-8.
72. Zhou M, Simms HH, Wang P. Adrenomedullin and adrenomedullin binding protein-1 attenuate vascular endothelial cell apoptosis in sepsis. Ann Surg. 2004;240:321-30.
73. Boos CJ, Mayr FB, Lip GYH, Jilma B. Endotoxemia enhances circulating endothelial cells in humans. J Thromb Haemost. 2006;4:2509-11.
74. Nguyen HB, Loomba M, Yang JJ, Jacobsen G, Shah K, Otero RM, et al. Early lactate clearance is associated with biomarkers of inflammation, coagulation, apoptosis, organ dysfunction and mortality in severe sepsis and septic shock. J Inflamm. 2010;7:6.
75. Joussen AM, Poulaki V, Mitsiades N, Cai W-Y, Suzuma I, Pak J, et al. Suppression of Fas-FasL-induced endothelial cell apoptosis prevents diabetic blood-retinal barrier breakdown in a model of streptozotocin-induced diabetes. FASEB J. 2003;17:76-8.
76. Rudkowski JC, Barreiro E, Harfouche R, Goldberg P, Kishta O, D'Orleans-Juste P, et al. Roles of iNOS and nNOS in sepsis-induced pulmonary apoptosis. Am J Physiol Lung Cell Mol Physiol. 2004;286:L793-800.
77. Liaudet L, Rosenblatt-Velin N, Pacher P. Role of peroxynitrite in the cardiovascular dysfunction of septic shock. Curr Vasc Pharmacol. 2013;11:196-207.
78. Lang JD, McArdle PJ, O'Reilly PJ, Matalon S. Oxidant-antioxidant balance in acute lung injury. Chest. 2002;122:314S-20S.
79. Li J-M, Fan LM, George VT, Brooks G. Nox2 regulates endothelial cell cycle arrest and apoptosis via p21cip1 and p53. Free Radic Biol Med. 2007;43:976-86.
80. Li G, Scull C, Ozcan L, Tabas I. NADPH oxidase links endoplasmic reticulum stress, oxidative stress, and PKR activation to induce apoptosis. J Cell Biol. 2010;191:1113-25.
81. Kindt GC, Gadek JE, Weiland JE. Initial recruitment of neutrophils to alveolar structures in acute lung injury. J Appl Physiol. 1991;70:1575-85.
82. Hasleton PS, Roberts TE. Adult respiratory distress syndrome - an update. Histopathology. 1999;34:285-94.
83. Grommes J, Soehnlein O. Contribution of neutrophils to acute lung injury. Mol Med. 2011;17:293-307.
84. Wang Q, Pfeiffer GR, Stevens T, Doerschuk CM. Lung microvascular and arterial endothelial cells differ in their responses to intercellular adhesion molecule-1 ligation. Am J Respir Crit Care Med. 2002;166:872-7.
85. DiStasi MR, Ley K. Opening the flood-gates: how neutrophil-endothelial interactions regulate permeability. Trends Immunol. 2009;30:547-56.
86. Green DR, Ferguson T, Zitvogel L, Kroemer G. Immunogenic and tolerogenic cell death. Nat Rev Immunol. 2009;9:353-63.
87. Bombeli T, Karsan A, Tait JF, Harlan JM. Apoptotic vascular endothelial cells become procoagulant. Blood. 1997;89:2429-42.
88. Hébert MJ, Gullans SR, Mackenzie HS, Brady HR. Apoptosis of endothelial cells is associated with paracrine induction of adhesion molecules: evidence for an interleukin-1beta-dependent paracrine loop. AJPA. 1998;152:523-32.
89. Zhao J, Chen L, Shu B, Tang J, Zhang L, Xie J, et al. Granulocyte/macrophage colony-stimulating factor attenuates endothelial hyperpermeability after thermal injury. Am J Transl Res. 2015;7:474-88.
90. Sharma S, Smith A, Kumar S, Aggarwal S, Rehmani I, Snead C, et al. Mechanisms of nitric oxide synthase uncoupling in endotoxin-induced acute lung injury: role of asymmetric dimethylarginine. Vascul Pharmacol. 2010;52:182-90.
91. Wu F, Szczepaniak WS, Shiva S, Liu H, Wang Y, Wang L, et al. Nox2-dependent glutathionylation of endothelial NOS leads to uncoupled superoxide production and endothelial barrier dysfunction in acute lung injury. Am J Physiol Lung Cell Mol Physiol. 2014;307:L987-97.
92. Heumüller S, Heumuller S, Wind S, Wind S, Barbosa-Sicard E, Barbosa-Sicard E, et al. Apocynin is not an inhibitor of vascular NADPH oxidases but an antioxidant. Hypertension. 2008;51:211-7.